Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiopoietin-2 (Ang-2) is a secreted glycoprotein and growth factor that plays a central role in the regulation of angiogenesis and inflammation. It primarily acts as an antagonist of the Tie2 receptor, blocking the stabilizing effects of Angiopoietin-1 (Ang1) on blood vessels, but can act as a weak agonist under certain conditions. Ang-2 modulates vascular permeability, endothelial cell migration and proliferation, and blood vessel destabilization/remodeling. Its dysregulation contributes significantly to pathological processes involving abnormal blood vessel growth or permeability such as cancer progression and inflammatory diseases.
Inhibition of Ang-2 and VEGF-A binding to their native receptors (e.g., Tie2)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiopoietin-2 (Ang-2).